selexipag 0.4 MG Oral Tablet [Uptravi]

RxNorm concept 1729057, branded drug (sbd). Prescribable name: Uptravi 400 MCG Oral Tablet.

RxCUI: 1729057
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1729057 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

selexipag 1729002

Other names

Uptravi 0.4 MG Oral Tablet; Uptravi 400 MCG Oral Tablet

Related concepts

selexipag 0.4 MG (SCDC, consists of)
selexipag 0.4 MG [Uptravi] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Uptravi (BN, has ingredient)
selexipag 0.4 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

66215060406

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1729057 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1729057 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1729057. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.